Dr. Douglas Galasko, a primary investigator in the clinical trials of a new Alzheimer's drug at UCSD speaks with News 8's Marcella Lee about the drug's FDA approval.
KFMB would like to send you push notifications about the latest news and weather.
Notifications can be turned off anytime in the browser settings.
